MediPharm Labs (TSX: LABS; OTCQB: MEDIF; FSE: MLZ) has announced that its CEO, David Pidduck, will step down from his role as of January 23, 2026, and that Greg Hunter, the company’s CFO, has been appointed interim CEO...
MediPharm Labs (TSX:LABS; OTCQX:MEDIF) has announced an agreement with Laboratório Teuto to expand its reach into the Brazilian medical cannabis market. The company states that it has been working closely with Teuto on...
Alliance Global Partners initiated coverage of MediPharm Labs (TSX:LABS) with a “buy” rating and price target of $2 (Canadian). The stock was quote at 82 cents around midday on Nov. 2. “We see MediPharm in a position to...